Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section description was updated to indicate that PubMed-listed publications are automatically filled and may not be about the study, and that the revision tag has changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice about data currency and NIH Clinical Center operations, and the guidance to check status updates on opm.gov. The page now lacks those status update instructions.SummaryDifference0.3%

- Check42 days agoChange DetectedNo substantive changes were observed; the differences appear to be minor formatting/layout adjustments with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference3%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element has been removed; overall content remains essentially the same.SummaryDifference0.2%

Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.